These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1309294

  • 1. Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase.
    Jarabak J.
    Arch Biochem Biophys; 1992 Jan; 292(1):239-43. PubMed ID: 1309294
    [Abstract] [Full Text] [Related]

  • 2. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalyzed by a human placental NADPH-linked carbonyl reductase.
    Jarabak J.
    Arch Biochem Biophys; 1991 Dec; 291(2):334-8. PubMed ID: 1659323
    [Abstract] [Full Text] [Related]

  • 3. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalysed by a human placental 17beta-hydroxysteroid dehydrogenase.
    Jarabak R, Harvey RG, Jarabak J.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):174-80. PubMed ID: 8615688
    [Abstract] [Full Text] [Related]

  • 4. Redox cycling of polycyclic aromatic hydrocarbon o-quinones: metal ion-catalyzed oxidation of catechols bypasses inhibition by superoxide dismutase.
    Jarabak R, Harvey RG, Jarabak J.
    Chem Biol Interact; 1998 Oct 02; 115(3):201-13. PubMed ID: 9851290
    [Abstract] [Full Text] [Related]

  • 5. Polycyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.
    Chung HS, Harvey RG, Armstrong RN, Jarabak J.
    J Biol Chem; 1987 Sep 15; 262(26):12448-51. PubMed ID: 3624267
    [Abstract] [Full Text] [Related]

  • 6. Studies on three reductases which have polycyclic aromatic hydrocarbon quinones as substrates.
    Jarabak J, Harvey RG.
    Arch Biochem Biophys; 1993 Jun 15; 303(2):394-401. PubMed ID: 7685581
    [Abstract] [Full Text] [Related]

  • 7. Redox cycling of polycyclic aromatic hydrocarbon o-quinones: reversal of superoxide dismutase inhibition by ascorbate.
    Jarabak R, Harvey RG, Jarabak J.
    Arch Biochem Biophys; 1997 Mar 01; 339(1):92-8. PubMed ID: 9056238
    [Abstract] [Full Text] [Related]

  • 8. Irreversible inhibition of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase/9-ketoprostaglandin reductase by glutathione thiosulfonate.
    Chung H, Fried J, Jarabak J.
    Prostaglandins; 1987 Mar 01; 33(3):391-402. PubMed ID: 3575754
    [Abstract] [Full Text] [Related]

  • 9. Substrate specificity of three prostaglandin dehydrogenases.
    Jarabak J, Luncsford A, Berkowitz D.
    Prostaglandins; 1983 Dec 01; 26(6):849-68. PubMed ID: 6396732
    [Abstract] [Full Text] [Related]

  • 10. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.
    Jarabak J, Fried J.
    Prostaglandins; 1979 Aug 01; 18(2):241-6. PubMed ID: 42948
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells.
    Flowers-Geary L, Harvey RG, Penning TM.
    Chem Res Toxicol; 1993 Aug 01; 6(3):252-60. PubMed ID: 7686407
    [Abstract] [Full Text] [Related]

  • 12. Glutathione mixed disulfide inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.
    Chung H, Fried J, Williams-Ashman E, Jarabak J.
    Prostaglandins; 1987 Mar 01; 33(3):383-90. PubMed ID: 3575753
    [Abstract] [Full Text] [Related]

  • 13. Aromatic hydrocarbon quinone-mediated reactive oxygen species production on hepatic microsomes of the flounder (Platichthys flesus L.).
    Lemaire P, Livingstone DR.
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Jun 01; 117(2):131-9. PubMed ID: 9214713
    [Abstract] [Full Text] [Related]

  • 14. Kinetic studies on 15-hydroxyprostaglandin dehydrogenase from human placenta.
    Schlegel W, Greep RO.
    Adv Prostaglandin Thromboxane Res; 1976 Jun 01; 1():159-62. PubMed ID: 187034
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of pulmonary NAD+-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein.
    Liu Y, Tai HH.
    Biochem Pharmacol; 1985 Dec 15; 34(24):4275-8. PubMed ID: 4074386
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases by nonsteroidal anti-inflammatory drugs.
    Jarabak J.
    Prostaglandins; 1988 Mar 15; 35(3):403-11. PubMed ID: 3375453
    [Abstract] [Full Text] [Related]

  • 17. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue.
    Westbrook C, Lin YM, Jarabak J.
    Biochem Biophys Res Commun; 1977 Jun 06; 76(3):943-9. PubMed ID: 20082
    [No Abstract] [Full Text] [Related]

  • 18. Endogenous inhibitor of 15-hydroxyprostaglandin dehydrogenase in human placenta.
    Nagai K, Mibe M, Mori N.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec 06; 38(3):157-61. PubMed ID: 2622970
    [Abstract] [Full Text] [Related]

  • 19. Early steps in prostaglandin metabolism in the human placenta.
    Jarabak J.
    Am J Obstet Gynecol; 1980 Nov 01; 138(5):534-40. PubMed ID: 6252782
    [Abstract] [Full Text] [Related]

  • 20. DNA strand scission by polycyclic aromatic hydrocarbon o-quinones: role of reactive oxygen species, Cu(II)/Cu(I) redox cycling, and o-semiquinone anion radicals,
    Flowers L, Ohnishi ST, Penning TM.
    Biochemistry; 1997 Jul 15; 36(28):8640-8. PubMed ID: 9214311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.